Chenhui Bao, Jiayan Gu, Xin Huang, Liangshun You, Ziyang Zhou & Jie Jin. (2023) Cytokine profiles in patients with newly diagnosed diffuse large B-cell lymphoma: IL-6 and IL-10 levels are associated with adverse clinical features and poor outcomes. Cytokine 169, pages 156289.
Crossref
Dong-Na Yang, Li-Ming Zhong & Feng-Qiong Huang. (2023) Clinical effect of standardized nursing for lymphoma patients and the influencing factors of nosocomial infection. Medicine 102:3, pages e32624.
Crossref
Narendranath Epperla, Walter Hanel & Moshe Talpaz. 2017. Holland‐Frei Cancer Medicine. Holland‐Frei Cancer Medicine
1
21
.
MarwaAhmed Gamaleldin, MayadaAly Moussa & SalmaAlaa Eldin Imbaby. (2022) Role of interleukin-10 (1082G/A) and splicing factor 3B subunit 1 (2098A/G) gene polymorphisms in chronic lymphocytic leukemia. Journal of Applied Hematology 13:2, pages 76.
Crossref
Marcus Bauer, Simon Jasinski-Bergner, Ofer Mandelboim, Claudia Wickenhauser & Barbara Seliger. (2021) Epstein–Barr Virus—Associated Malignancies and Immune Escape: The Role of the Tumor Microenvironment and Tumor Cell Evasion Strategies. Cancers 13:20, pages 5189.
Crossref
Laura E. Martínez, Tracy R. Daniels-Wells, Yu Guo, Larry I. Magpantay, Pierre V. Candelaria, Manuel L. Penichet, Otoniel Martínez-Maza & Marta Epeldegui. (2021) Targeting TfR1 with the ch128.1/IgG1 Antibody Inhibits EBV-driven Lymphomagenesis in Immunosuppressed Mice Bearing EBV+ Human Primary B-cells. Molecular Cancer Therapeutics 20:9, pages 1592-1602.
Crossref
Kyle P. D’mello, Lei Zhao, Erin C. Kaser, Ziwen Zhu, Huaping Xiao, Mark R. Wakefield, Qian Bai & Yujiang Fang. (2021) The role of interleukins and the widely studied TNF-α in non-Hodgkin’s lymphoma. Medical Oncology 38:5.
Crossref
Maria Teresa Gonzalez-Garza, Delia Elva Cruz-Vega & Carmen Maldonado-Bernal. 2021. Translational Research in Cancer. Translational Research in Cancer.
Alexandra Ladouceur, Hiromi Tissera, Ann E. Clarke, Rosalind Ramsey-Goldman, Caroline Gordon, James E. Hansen & Sasha Bernatsky. 2021. Systemic Lupus Erythematosus. Systemic Lupus Erythematosus
461
467
.
Shaghayegh Khanmohammadi, Mahsima Shabani, Mohammadreza Tabary, Elham Rayzan & Nima Rezaei. (2020) Lymphoma in the setting of autoimmune diseases: A review of association and mechanisms. Critical Reviews in Oncology/Hematology 150, pages 102945.
Crossref
Li Gao, Haige Han, Honglei Wang, Li Cao & Wen-hai Feng. (2019) IL-10 knockdown with siRNA enhances the efficacy of Doxorubicin chemotherapy in EBV-positive tumors by inducing lytic cycle via PI3K/p38 MAPK/NF-kB pathway. Cancer Letters 462, pages 12-22.
Crossref
Leila Sawada, Yoshiko Nagano, Atsuhiko Hasegawa, Hikari Kanai, Kai Nogami, Sayaka Ito, Tomoo Sato, Yoshihisa Yamano, Yuetsu Tanaka, Takao Masuda & Mari Kannagi. (2017) IL-10-mediated signals act as a switch for lymphoproliferation in Human T-cell leukemia virus type-1 infection by activating the STAT3 and IRF4 pathways. PLOS Pathogens 13:9, pages e1006597.
Crossref
Ravi Maddaly, Aishwarya Subramaniyan & Harini Balasubramanian. (2017) Cancer Cytokines and the Relevance of 3D Cultures for Studying Those Implicated in Human Cancers. Journal of Cellular Biochemistry 118:9, pages 2544-2558.
Crossref
Maria Cosenza, Monica Civallero, Luigi Marcheselli, Stefano Sacchi & Samantha Pozzi. (2017) Ricolinostat, a selective HDAC6 inhibitor, shows anti-lymphoma cell activity alone and in combination with bendamustine. Apoptosis 22:6, pages 827-840.
Crossref
Suhendan Ekmekcioglu & Elizabeth A. Grimm. 2016. Holland‐Frei Cancer Medicine. Holland‐Frei Cancer Medicine
1
17
.
Renu Verma, Lavanya Balakrishnan, Kusum Sharma, Aafaque Ahmad Khan, Jayshree Advani, Harsha Gowda, Srikanth Prasad Tripathy, Mrutyunjay Suar, Akhilesh Pandey, Sheetal Gandotra, T. S. Keshava Prasad & Subramanian Shankar. (2015) A network map of Interleukin-10 signaling pathway. Journal of Cell Communication and Signaling 10:1, pages 61-67.
Crossref
Hiromi Tissera, Ann E. Clarke, Rosalind Ramsey Goldman, Caroline Gordon, James E. Hansen & Sasha Bernatsky. 2016. Systemic Lupus Erythematosus. Systemic Lupus Erythematosus
411
415
.
V. A. Ovsepyan, A. Kh. Gabdulkhakova, A. A. Shubenkiva & E. N. Zotina. (2015) Role of Interleukin-10 Gene Promoter Region Polymorphism in the Development of Chronic Lymphoid Leukemia. Bulletin of Experimental Biology and Medicine 160:2, pages 275-277.
Crossref
Holly L. Geyer, Amylou C. Dueck, Robyn M. Scherber & Ruben A. Mesa. (2015) Impact of Inflammation on Myeloproliferative Neoplasm Symptom Development. Mediators of Inflammation 2015, pages 1-9.
Crossref
Suhendan Ekmekcioglu, Razelle Kurzrock & Elizabeth A. Grimm. 2015. The Molecular Basis of Cancer. The Molecular Basis of Cancer
789
808.e4
.
Rosalind Ramsey-Goldman, Sasha Bernatsky & Ann Clarke. (2014) Dialogue: what can we learn about the relationship between systemic lupus erythematosus and haematological malignancies from linking disease registries?. Lupus Science & Medicine 1:1, pages e000068.
Crossref
Kerstin L. Edlefsen, Otoniel Martínez-Maza, Margaret M. Madeleine, Larry Magpantay, Dana K. Mirick, Kenneth J. Kopecky, Andrea Z. LaCroix & Anneclaire J. De Roos. (2014) Cytokines in serum in relation to future non-Hodgkin lymphoma risk: Evidence for associations by histologic subtype. International Journal of Cancer 135:4, pages 913-922.
Crossref
Jingsheng Tuo, Defen Shen, Howard Hua Yang & Chi-Chao Chan. (2014) Distinct MicroRNA-155 Expression in the Vitreous of Patients With Primary Vitreoretinal Lymphoma and Uveitis. American Journal of Ophthalmology 157:3, pages 728-734.
Crossref
Ryan Incrocci, Molly McCormack & Michelle Swanson-Mungerson. (2013) Epstein–Barr virus LMP2A increases IL-10 production in mitogen-stimulated primary B-cells and B-cell lymphomas. Journal of General Virology 94:5, pages 1127-1133.
Crossref
Christina Heemann, Markus Kreuz, Irene Stoller, Nils Schoof, Frederike von Bonin, Marita Ziepert, Markus Löffler, Wolfram Jung, Michael Pfreundschuh, Lorenz Trümper & Dieter Kube. (2012) Circulating Levels of TNF Receptor II Are Prognostic for Patients with Peripheral T-cell Non–Hodgkin Lymphoma. Clinical Cancer Research 18:13, pages 3637-3647.
Crossref
Paul M. Barr, Chungwen Wei, James Roger, Julia Schaefer-Cutillo, Jennifer L. Kelly, Alexander F. Rosenberg, John Jung, I?aki Sanz & Jonathan W. Friedberg. (2012) Syk inhibition with fostamatinib leads to transitional B lymphocyte depletion. Clinical Immunology 142:3, pages 237-242.
Crossref
Xiaoguang Cao, Defen Shen, David G. Callanan, Manabu Mochizuki & Chi-Chao Chan. (2011) Diagnosis of systemic metastatic retinal lymphoma. Acta Ophthalmologica 89:2, pages e149-e154.
Crossref
Kamini Singh, Surajit Sinha, Sunil Kumar Malonia, Pradeep Bist, Vinay Tergaonkar & Samit Chattopadhyay. (2009) Tumor Suppressor SMAR1 Represses IκBα Expression and Inhibits p65 Transactivation through Matrix Attachment Regions. Journal of Biological Chemistry 284:2, pages 1267-1278.
Crossref
Antica Duletić-Načinović, Sanja Štifter, Blažen Marijić, Ksenija Lučin, Toni Valković, Duška Petranović & Nives Jonjić. (2018)
Serum IL-6, IL-8, IL-10 and Beta
2
-Microglobulin in Association with International Prognostic Index in Diffuse Large B Cell Lymphoma
. Tumori Journal 94:4, pages 511-517.
Crossref
J. S. Lee, P. M. Bracci & E. A. Holly. (2008) Non-Hodgkin Lymphoma in Women: Reproductive Factors and Exogenous Hormone Use. American Journal of Epidemiology 168:3, pages 278-288.
Crossref
A. NAČINOVIĆ-DULETIĆ, S. ŠTIFTER, Š. DVORNIK, Ž. ŠKUNCA & NIVES JONJIĆ. (2008) Correlation of serum IL-6, IL-8 and IL-10 levels with clinicopathological features and prognosis in patients with diffuse large B-cell lymphoma. International Journal of Laboratory Hematology 30:3, pages 230-239.
Crossref
Gertraud Maskarinec, Eva Erber, Jasmeet Gill, Wendy Cozen & Laurence N. Kolonel. (2008) Overweight and Obesity at Different Times in Life as Risk Factors for Non-Hodgkin's Lymphoma: The Multiethnic Cohort. Cancer Epidemiology, Biomarkers & Prevention 17:1, pages 196-203.
Crossref
Suhendan Ekmekcioglu, Razelle Kurzrock & Elizabeth A. Grimm. 2008. The Molecular Basis of Cancer. The Molecular Basis of Cancer
605
619
.
Chi-Chao Chan, John A. Gonzales & Ahmed A. Hidayat. 2008. Albert & Jakobiec's Principles & Practice of Ophthalmology. Albert & Jakobiec's Principles & Practice of Ophthalmology
1255
1280
.
Dong Hwan Kim. 2009. Genomics and Pharmacogenomics in Anticancer Drug Development and Clinical Response. Genomics and Pharmacogenomics in Anticancer Drug Development and Clinical Response
203
229
.
Stacie L. Lambert & Olivia M. Martinez. (2007) Latent Membrane Protein 1 of EBV Activates Phosphatidylinositol 3-Kinase to Induce Production of IL-10. The Journal of Immunology 179:12, pages 8225-8234.
Crossref
Je‐Jung Lee, Dong Hwan Kim, Nan Young Lee, Sang Kyun Sohn, Jong Gwang Kim, Hyeoung‐Joon Kim, Young Rok Do & Yeon Hee Park. (2007) Interleukin‐10 gene polymorphism influences the prognosis of T‐cell non‐Hodgkin lymphomas. British Journal of Haematology 137:4, pages 329-336.
Crossref
Ismail Oguz Kara, Berksoy Sahin & Ramazan Gunesacar. (2007) Expression of soluble CD27 and interleukins-8 and -10 in B-cell chronic lymphocytic leukemia: Correlation with disease stage and prognosis. Advances in Therapy 24:1, pages 29-40.
Crossref
E. Dawn Flick, K. Arnold Chan, Paige M. Bracci & Elizabeth A. Holly. (2006) Use of Nonsteroidal Antiinflammatory Drugs and Non-Hodgkin Lymphoma: A Population-based Case-Control Study. American Journal of Epidemiology 164:5, pages 497-504.
Crossref
Yong Wei & Jessie L.-S. Au. 2005. Integration/Interaction of Oncologic Growth. Integration/Interaction of Oncologic Growth
285
321
.
Behnam Ebrahimi, Susan L. Tucker, Donghui Li, James L. Abbruzzese & Razelle Kurzrock. (2004) Cytokines in pancreatic carcinoma. Cancer 101:12, pages 2727-2736.
Crossref
Nikolaus Becker, Evelin Deeg & Alexandra Nieters. (2004) Population-based study of lymphoma in Germany: rationale, study design and first results. Leukemia Research 28:7, pages 713-724.
Crossref
C HAHN, M AL & J TEW. (2004) Comparison of Type 1 and Type 2 Cytokine Production by Mononuclear Cells Cultured With Streptococcus mutans and Selected Other Caries Bacteria. Journal of Endodontics 30:5, pages 333-338.
Crossref
Thomas Zander, Daniel Re, Michael von Bergwelt-Baildon, Jürgen Wolf & Joachim L. Schultze. 2004. Cancer Immunotherapy at the Crossroads. Cancer Immunotherapy at the Crossroads
295
314
.
K. Asadullah, W. Sterry & H. D. Volk. (2003) Interleukin-10 Therapy—Review of a New Approach. Pharmacological Reviews 55:2, pages 241-269.
Crossref
Segolene Mahot, Alain Sergeant, Emmanuel Drouet & Henri Gruffat. (2003) A novel function for the Epstein–Barr virus transcription factor EB1/Zta: induction of transcription of the hIL-10 gene. Journal of General Virology 84:4, pages 965-974.
Crossref
Sergey V. Sennikov, Sergey V. Krysov, Tatiana V. Injelevskaya, Alexandr N. Silkov, Lyubov V. Grishina & Vladimir A. Kozlov. (2003) Quantitative analysis of human immunoregulatory cytokines by electrochemiluminescence method. Journal of Immunological Methods 275:1-2, pages 81-88.
Crossref
Tatsuharu Ohno, Yasunori Ueda, Ken-ichi Nagai, Takayuki Takahashi, Yoshiteru Konaka, Teruyuki Takamatsu, Takayo Suzuki, Masataka Sasada & Takashi Uchiyama. (2003) The Serum Cytokine Profiles of Lymphoma-associated Hemophagocytic Syndrome: A Comparative Analysis of B-Cell and T-Cell/Natural Killer Cell Lymphomas. International Journal of Hematology 77:3, pages 286-294.
Crossref
Fazil Aydin, Mustafa Yilmaz, Feyyaz Özdemir, Halil Kavgaci, Melek Nur Yavuz & Ali Aydin Yavuz. (2002) Correlation of Serum IL-2, IL-6 and IL-10 Levels With International Prognostic Index in Patients With Aggressive Non-Hodgkin’s Lymphoma. American Journal of Clinical Oncology 25:6, pages 570-572.
Crossref
I Y Rosenblum & A D Dayan. (2016) Carcinogenicity testing of IL-10: principles and practicalities. Human & Experimental Toxicology 21:7, pages 347-358.
Crossref
Annette Boehler. (2002) The role of interleukin-10 in lung transplantation. Transplant Immunology 9:2-4, pages 121-124.
Crossref
R Kurzrock. (2001) Cytokine deregulation in cancer. Biomedicine & Pharmacotherapy 55:9-10, pages 543-547.
Crossref
Razelle Kurzrock. (2001) The role of cytokines in cancer-related fatigue. Cancer 92:S6, pages 1684-1688.
Crossref
Kevin W. MooreRene de Waal MalefytRobert L. CoffmanAnne O'Garra. (2001) Interleukin-10 and the Interleukin-10 Receptor. Annual Review of Immunology 19:1, pages 683-765.
Crossref
Liliana GuedezAdnan MansoorBente Birkedal-HansenMegan S. LimPaula FukushimaDavid VenzonWilliam G. Stetler-StevensonMaryalice Stetler-Stevenson. (2001) Tissue inhibitor of metalloproteinases 1 regulation of interleukin-10 in B-cell differentiation and lymphomagenesis. Blood 97:6, pages 1796-1802.
Crossref
Nozomi NiitsuJunko Okabe-KadoMasataka OkamotoToshiyuki TakagiTakashi YoshidaSadao AokiMasami HiranoYoshio Honma. (2001) Serum nm23-H1 protein as a prognostic factor in aggressive non-Hodgkin lymphoma. Blood 97:5, pages 1202-1210.
Crossref
C.Stephen Foster & Esen K. Akpek. (2001) Author?s reply. Ophthalmology 108:3, pages 428.
Crossref
Luis FayadMichael J. KeatingJames M. ReubenSusan O'BrienBang-Ning LeeSusan LernerRazelle Kurzrock. (2001) Interleukin-6 and interleukin-10 levels in chronic lymphocytic leukemia: correlation with phenotypic characteristics and outcome. Blood 97:1, pages 256-263.
Crossref
Alok A. Khorana, Joseph D. Rosenblatt & Faith M. Young. 2001. HIV & HTLV-I Associated Malignancies. HIV & HTLV-I Associated Malignancies
19
74
.
P Vineis. (2000) Delayed infection, family size and malignant lymphomas. Journal of Epidemiology & Community Health 54:12, pages 907-911.
Crossref
M.B. Lappin & J.D.M. Campbell. (2000) The Th1-Th2 classification of cellular immune responses: concepts, current thinking and applications in haematological malignancy. Blood Reviews 14:4, pages 228-239.
Crossref
Deborah K. Duff, Suzanne Thompson, Stephen Braye, David Price, Mark Loewenthal & Michael J. Boyle. (2000) The cytokine milieu of HIV-associated non-Hodgkin's lymphoma favours aggressive tumours. AIDS 14:1, pages 92-94.
Crossref
Michael R. Shurin, Lina Lu, Pawel Kalinski, Ann M. Stewart-Akers & Michael T. Lotze. (1999) Th1/Th2 balance in cancer, transplantation and pregnancy. Springer Seminars in Immunopathology 21:3, pages 339-359.
Crossref
Robert A. Baiocchi & Michael A. Caligiuri. (1999) Cytokines in the evolution and treatment of AIDS-lymphoma. Current Opinion in Oncology 11:6, pages 516.
Crossref
Elli F Kamper, Anastasios D PapahilisS, Maria K Angelopoulou, Ludmila T Kopeikina, Marina P Siakantaris, Gerassimos A Pangalis & John C Stavrudis. (1999) Serum levels of tetranectin, intercellular adhesion molecule-1 and interleukin-10 in B-chronic lymphocytic leukemia. Clinical Biochemistry 32:8, pages 639-645.
Crossref
Anna E. KossakowskaDylan R. EdwardsChristopher PrusinkiewiczMelissa C. ZhangDianlin GuoStefan J. UrbanskiThomas GroganLeah A. MarquezAnna Janowska-Wieczorek. (1999) Interleukin-6 Regulation of Matrix Metalloproteinase (MMP-2 and MMP-9) and Tissue Inhibitor of Metalloproteinase (TIMP-1) Expression in Malignant Non-Hodgkin’s Lymphomas. Blood 94:6, pages 2080-2089.
Crossref
R.M. Beaty, K. Rulli, K.L. Bost, J. Pantginis, J. Lenz & L.S. Levy. (1999) High Levels of IL-4 and IL-10 mRNA and Low Levels of IL-2, IL-9 and IFN-γ mRNA in MuLV-Induced Lymphomas. Virology 261:2, pages 253-262.
Crossref
Sven Arvid Birkeland, Klaus Bendtzen, Bjarne M??ller, Stephen Hamilton-Dutoit & Hans Kerzel Andersen. (1999) INTERLEUKIN-10 AND POSTTRANSPLANT LYMPHOPROLIFERATIVE DISORDER AFTER KIDNEY TRANSPLANTATION1. Transplantation 67:6, pages 876-881.
Crossref